144 related articles for article (PubMed ID: 38643840)
1. The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine.
Pozzi S; Satchi-Fainaro R
Adv Drug Deliv Rev; 2024 Jun; 209():115318. PubMed ID: 38643840
[TBL] [Abstract][Full Text] [Related]
2. Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
Lim SY; Yuzhalin AE; Gordon-Weeks AN; Muschel RJ
Oncotarget; 2016 May; 7(19):28697-710. PubMed ID: 26885690
[TBL] [Abstract][Full Text] [Related]
3. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
4. Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?
Iwamoto H; Izumi K; Mizokami A
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33297571
[TBL] [Abstract][Full Text] [Related]
5. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
6. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M; Wang Y; Xia R; Wei Y; Wei X
Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity.
Dansereau MA; Midavaine É; Bégin-Lavallée V; Belkouch M; Beaudet N; Longpré JM; Mélik-Parsadaniantz S; Sarret P
J Neuroinflammation; 2021 Mar; 18(1):79. PubMed ID: 33757529
[TBL] [Abstract][Full Text] [Related]
8. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
Fei L; Ren X; Yu H; Zhan Y
Front Immunol; 2021; 12():771210. PubMed ID: 34804061
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-derived CCL2 participates in surgery-induced cognitive dysfunction and neuroinflammation via evoking microglia activation.
Xu J; Dong H; Qian Q; Zhang X; Wang Y; Jin W; Qian Y
Behav Brain Res; 2017 Aug; 332():145-153. PubMed ID: 28587818
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice.
Llorián-Salvador M; Pevida M; González-Rodríguez S; Lastra A; Fernández-García MT; Hidalgo A; Baamonde A; Menéndez L
Fundam Clin Pharmacol; 2016 Jun; 30(3):235-47. PubMed ID: 26820818
[TBL] [Abstract][Full Text] [Related]
11. Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents.
Yumimoto K; Sugiyama S; Mimori K; Nakayama KI
Cancer Sci; 2019 Jul; 110(7):2090-2099. PubMed ID: 31111571
[TBL] [Abstract][Full Text] [Related]
12. CCL2-CCR2 Signaling in Disease Pathogenesis.
O'Connor T; Borsig L; Heikenwalder M
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):105-18. PubMed ID: 25772168
[TBL] [Abstract][Full Text] [Related]
13. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
[TBL] [Abstract][Full Text] [Related]
14. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
15. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
[TBL] [Abstract][Full Text] [Related]
16. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
17. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2
Takacs GP; Kreiger CJ; Luo D; Tian G; Garcia JS; Deleyrolle LP; Mitchell DA; Harrison JK
Front Immunol; 2022; 13():993444. PubMed ID: 36685592
[TBL] [Abstract][Full Text] [Related]
18. CCL2/CCR2 signaling in cancer pathogenesis.
Hao Q; Vadgama JV; Wang P
Cell Commun Signal; 2020 May; 18(1):82. PubMed ID: 32471499
[TBL] [Abstract][Full Text] [Related]
19. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
20. The regulation and importance of monocyte chemoattractant protein-1.
Bianconi V; Sahebkar A; Atkin SL; Pirro M
Curr Opin Hematol; 2018 Jan; 25(1):44-51. PubMed ID: 28914666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
